13| Disclosing Alzheimer’s Disease Genetic Risk – A Conversation With Dr. Meghan Collier
02/01/19 • 96 min
Clinical trials in Alzheimer’s disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the public. Is it helpful or harmful for clinicians to disclose information on genetic risk for Alzheimer’s disease to patients and research participants? How can we explain concepts such as risk and incomplete penetrance to our patients? We pose these questions, and others, to a neuropsychologist with research and clinical experience in this arena, as well as provide a primer on genetics.
Show notes are available at www.NavNeuro.com/13
_________________
If you’d like to support the show, here are a few easy ways:
1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS
2) Tell your friends and colleagues about it
3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes
4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating
Thanks for listening, and join us next time as we continue to navigate the brain and behavior!
[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Clinical trials in Alzheimer’s disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the public. Is it helpful or harmful for clinicians to disclose information on genetic risk for Alzheimer’s disease to patients and research participants? How can we explain concepts such as risk and incomplete penetrance to our patients? We pose these questions, and others, to a neuropsychologist with research and clinical experience in this arena, as well as provide a primer on genetics.
Show notes are available at www.NavNeuro.com/13
_________________
If you’d like to support the show, here are a few easy ways:
1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS
2) Tell your friends and colleagues about it
3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes
4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating
Thanks for listening, and join us next time as we continue to navigate the brain and behavior!
[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Previous Episode
12| Inside NavNeuro: University of Florida ANST Q & A
We have a different kind of episode for you today. We were recently asked to speak about NavNeuro at an ANST brown bag lunch at the University of Florida. This episode is the audio from our Q & A with students who are particularly interested in the podcast and wanted to know more of the details about how we got started and what our plans are for the podcast, as well as a bit more about us on a personal level. We also cover lots of other interesting topics, like how to educate the general public and other clinicians about neuropsychology, how to explain difficult neuropsych concepts to a broad audience, and how to get into more controversial topics in the field.
Show notes are available at www.NavNeuro.com/12
_________________
If you’d like to support the show, here are a few easy ways:
1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS
2) Tell your friends and colleagues about it
3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes
4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating
Thanks for listening, and join us next time as we continue to navigate the brain and behavior!
[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Next Episode
14| Neuropsychology for Non-Neuropsychologists (Part 2)
We provided an overview of the field of neuropsychology in Episode 2, but we wanted to run it by someone outside the field to see if anything was unclear or if other questions came up. This episode is a Q & A with someone without any background in neuropsychology. We discuss lots of topics, such as the difference between normal and "abnormal" forgetfulness, why some people are able to process information quicker than others, the difference between dementia and Alzheimer's disease, and much more. Students, trainees, and the general public will likely benefit most from the content.
Show notes are available at www.NavNeuro.com/14
_________________
If you’d like to support the show, here are a few easy ways:
1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS
2) Tell your friends and colleagues about it
3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes
4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating
Thanks for listening, and join us next time as we continue to navigate the brain and behavior!
[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/navigating-neuropsychology-108026/13-disclosing-alzheimers-disease-genetic-risk-a-conversation-with-dr-m-5592513"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 13| disclosing alzheimer’s disease genetic risk – a conversation with dr. meghan collier on goodpods" style="width: 225px" /> </a>
Copy